Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,583 | -1,669 | -871 | -21,010 | -3,213 |
| Depreciation Amortization | 660 | 546 | 359 | 6,578 | 1,019 |
| Income taxes - deferred | 0 | 0 | N/A | 4,100 | -450 |
| Accounts receivable | 749 | 657 | 381 | -7 | -675 |
| Accounts payable and accrued liabilities | -113 | -18 | -602 | -1,500 | 1,426 |
| Other Working Capital | 698 | 136 | -88 | 4 | 139 |
| Other Operating Activity | 390 | -465 | 396 | 9,200 | -453 |
| Operating Cash Flow | $-1,199 | $-814 | $-425 | $-2,635 | $-2,207 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | N/A | -3 | N/A | N/A |
| PPE Investments | -3 | -1 | N/A | -255 | 3 |
| Net Acquisitions | 2,678 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -59 | -268 |
| Other Investing Activity | 1,554 | 39 | 23 | 269 | 274 |
| Investing Cash Flow | $4,230 | $38 | $20 | $-45 | $9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -229 | 23 |
| Debt Repayment | 8 | N/A | N/A | -200 | -200 |
| Common Stock Issued | N/A | 0 | N/A | 3,911 | 3,001 |
| Other Financing Activity | 0 | 0 | 0 | -67 | 0 |
| Financing Cash Flow | $8 | $0 | $N/A | $3,415 | $2,824 |
| Exchange Rate Effect | -177 | -41 | -1 | 5 | 2 |
| Beginning Cash Position | 1,583 | 1,583 | 1,583 | 843 | 843 |
| End Cash Position | 4,445 | 767 | 1,178 | 1,583 | 1,470 |
| Net Cash Flow | $2,862 | $-817 | $-406 | $740 | $627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,199 | -814 | -425 | -2,635 | -2,207 |
| Capital Expenditure | -3 | 0 | N/A | -285 | N/A |
| Free Cash Flow | -1,202 | -814 | -425 | -2,920 | -2,207 |